Retinal Disease · Surgeon Series
The retina is
already failing. The lens
doesn't have to.
Retinitis pigmentosa takes vision slowly, from the outside in — night blindness first, then a shrinking field, then, in advanced disease, a narrow island of central sight. Along the way, most patients develop a cataract earlier than their peers. Removing it is routine surgery on a very unforgiving eye: there is little visual reserve left to spend on an avoidable complication, and the lens implant chosen has to respect that.
vs. general population
the typical pattern
in most RP eyes
Section 01 — What Retinitis Pigmentosa Actually Does
Not one disease.
One shared
pattern of loss.
Retinitis pigmentosa (RP) is not a single condition but a group of inherited retinal disorders that share a common mechanism: progressive degeneration of the photoreceptors, the rod and cone cells that convert light into the signal the brain reads as vision. It is the most common inherited retinal degeneration, and it follows a recognisable arc even though the underlying genetics vary widely from patient to patient.
Rods, which are concentrated in the peripheral retina and handle low-light and night vision, are usually lost first. That is why night blindness is typically the earliest symptom, often noticed years or decades before any change in daytime vision. As rod loss spreads, the visual field narrows from the outside in — the classic "tunnel vision" patients describe, though the corridor closes gradually rather than all at once. Cone cells, concentrated in the central macula and responsible for daytime and colour vision, are generally affected later. In advanced disease, a patient can be left with a small island of central vision surrounded by a visual field that has effectively gone dark, even though that central island itself may still register a reasonable letter-chart acuity.
RP is genetic, and the inheritance pattern varies by family and by which of the many genes implicated is involved — autosomal dominant, autosomal recessive and X-linked forms all occur, which is part of why the rate and pattern of progression can differ so much from one patient to the next, and even between the two eyes of the same person. A minority of cases occur as part of a broader syndrome rather than in isolation — Usher syndrome, which combines RP with hearing loss, is the best known example. None of that genetic detail changes how a cataract in an RP eye is surgically managed, but it does explain why two patients with the same "retinitis pigmentosa" label on their chart can present at very different stages and with very different remaining function, which is exactly why a generic surgical plan doesn't serve this population well and an individualised one does.
RP is progressive photoreceptor degeneration, rods before cones, causing night blindness first, then a visual field that constricts from the periphery inward, then — in advanced cases — loss of central vision too. It is genetic, currently has no cure that restores lost photoreceptors, and its rate of progression varies significantly between patients and even between the two eyes of the same patient. What makes RP relevant to cataract surgery specifically is that it also predisposes to an earlier-onset cataract, most often a posterior subcapsular pattern, layering a second, treatable cause of vision loss on top of the one that isn't.
Section 02 — Interactive
Watch the field
close in, stage by stage.
The single hardest thing to communicate about RP to someone who hasn't experienced it is that the visual field narrows gradually, while the remaining central vision can still look sharp on a chart. Select a stage below to see an illustrative approximation of how the usable field changes as RP advances — not a diagnostic tool, and not a specific patient's actual field, but a way to build the right intuition before the surgical discussion that follows.
In early disease, the field is often near-normal by day and the main complaint is night vision — missing a step in dim light, struggling in a poorly lit room, headlights feeling unusually harsh. By moderate disease, patients commonly describe bumping into things at their sides, missing objects that would be in a normal peripheral field, and a growing reliance on turning the head to compensate. In advanced disease, what remains can be a narrow central corridor of vision — still potentially useful for tasks like reading or recognising faces directly in front of them, but offering little to no awareness of anything beside or around that corridor.
Section 03 — The Cataract Connection
Why the lens clouds
earlier when the
retina is already failing.
Cataract is not part of the genetic definition of RP, but it is one of the most consistently reported associated findings, and posterior subcapsular cataract (PSC) in particular shows up disproportionately often in RP patients, frequently at a younger age than typical age-related cataract. The exact mechanism isn't fully settled — proposed contributors include the chronic low-grade inflammatory and oxidative changes associated with ongoing photoreceptor degeneration — but the clinical pattern itself is well documented and familiar to any surgeon who sees a reasonable volume of RP patients.
PSC cataracts have a specific clinical signature relevant here: because the opacity sits at the back of the lens, directly in the visual axis, it tends to cause disproportionate glare and contrast loss relative to its size, especially in bright light or when the pupil constricts. For a patient with a normal retina, that's an inconvenience corrected by routine surgery. For a patient whose retina is already degenerating, that same glare and contrast loss lands on a visual system with far less capacity to compensate — which is a large part of why RP patients often present for cataract surgery with more functional complaint, and often somewhat earlier, than their lens opacity alone might suggest to an examiner comparing it to a standard age-related cataract.
| Factor | Typical age-related cataract | Cataract in RP |
|---|---|---|
| Usual pattern | Nuclear sclerotic or mixed | Posterior subcapsular, disproportionately common |
| Typical age of onset | Later, gradual with age | Often earlier than age-matched peers without RP |
| Retina behind it | Usually healthy | Already degenerating, field already reduced |
| Visual reserve to spare | Typically substantial | Often limited — little margin for additional insult |
| Functional impact of the cataract | Proportional to lens opacity | Can feel disproportionately large given how little field/contrast is left to lose |
None of this changes how the cataract itself is removed — phacoemulsification technique is the same operation regardless of what's happening at the retina. What it changes is how much the surgeon has to get right the first time, because there's less visual budget available to absorb a complication and still leave the patient better off than before.
There's also a practical diagnostic wrinkle worth naming: because RP already causes glare sensitivity and reduced contrast on its own, a mild-to-moderate cataract can sometimes be under-recognised on routine slit-lamp exam in an RP patient, since the examiner may reasonably attribute some of the reported visual complaint to the known retinal disease rather than to a treatable lens change sitting on top of it. A careful, dilated exam that doesn't stop investigating once "the retina explains it" is part of good practice in this population — a genuinely reversible cataract is easy to miss if it's assumed away.
Section 04 — IOL Selection
Why almost every
surgeon reaches for
the same lens type.
Multifocal and extended-depth-of-focus (EDOF) IOLs have become a standard offering in modern cataract surgery for patients who want reduced spectacle dependence, and they work well for many people with a healthy retina. In retinitis pigmentosa, most surgeons make a deliberate, near-universal exception: a monofocal IOL, not a multifocal or EDOF design, is the conventional default.
The reason is optical, not a blanket rule against premium lenses. Multifocal and EDOF optics work by splitting incoming light between two or more focal points simultaneously, which necessarily reduces the light and contrast delivered to any single focal plane compared with a monofocal lens that sends essentially all of it to one point. A retina with normal photoreceptor density and function can usually absorb that trade-off comfortably in exchange for spectacle independence. A retina already losing photoreceptors to RP has less contrast sensitivity to spare, and asking it to also process a split, lower-contrast image is generally considered an unnecessary added burden on a system that's already working with less.
This is a general pattern surgeons apply, not an absolute rule for every case — disease severity, remaining field, patient goals and individual retinal function all factor into a real decision made with a specific patient's retina specialist input where available. But as defaults go, it's about as close to universal as cataract-surgery decision-making gets: give an already-compromised retina the cleanest, highest-contrast image available, and don't add optical complexity it didn't ask for.
Biometry is harder to get right, too
IOL power calculation depends on accurate preoperative measurements — axial length, corneal curvature, anterior chamber depth — and on the patient holding steady fixation while some of those measurements are taken. RP can complicate that step in ways a standard cataract workup doesn't anticipate: nystagmus (involuntary eye movement) is present in some RP patients, especially those with earlier-onset or syndromic forms, and unsteady fixation can reduce the accuracy of keratometry and optical biometry alike. Surgeons managing these cases often take extra measurements, cross-check with more than one biometry method, and build in a wider margin of clinical judgement around the calculated IOL power rather than trusting a single automated readout as they might in a routine case.
Section 05 — What the Reserve Actually Costs
When there's no
margin left, every detail
in the tray matters.
"Limited visual reserve" is a phrase that's easy to say and easy to underweight in practice. It means, concretely, that an intraoperative or postoperative event a healthy-retina patient would barely notice — a few hours of extra corneal edema, a mild inflammatory reaction, a slow-forming PCO two years later — can represent a proportionally much larger hit to an RP patient's already-reduced visual world.
Illustrative representation of how these priorities generally shift for an RP patient relative to a standard-risk cataract case, based on the clinical reasoning described in this article — not a scored index, a validated instrument, or pooled trial data.
retinal degeneration
rods, then cones
cataract surgery alone
None of this is exotic surgery. It's the same phacoemulsification, the same capsulorhexis, the same IOL insertion any cataract surgeon performs routinely. What changes is the tolerance for anything less than the cleanest possible execution — a cohesive-then-dispersive OVD strategy that genuinely protects the corneal endothelium through the phaco step, an IOL with a real square-edge posterior capsule barrier, and gentle, unhurried handling rather than a rushed routine case. In an eye with reserve to spare, small technical shortcuts are usually invisible in the outcome. In an RP eye, they're the difference the patient actually feels.
Section 06 — Setting Honest Expectations
What surgery fixes.
What it can't touch.
The single most important conversation in RP cataract surgery happens before the operating room, not in it. A patient with advanced RP who has heard "cataract surgery" and "vision improvement" in the same sentence needs to leave that conversation understanding precisely what is being offered.
A patient in their fifties with a decades-long RP diagnosis has a visual field reduced to a small central island in each eye, now further clouded by bilateral posterior subcapsular cataracts. Reading has become difficult, faces at a distance are hard to make out, and bright rooms are increasingly uncomfortable. Cataract surgery with a monofocal IOL, careful endothelial protection and a square-edge PCO-barrier lens is performed on the more affected eye first.
The visual field afterward is unchanged — surgery does not touch the RP itself, and nothing about the corridor's width is different. But within that corridor, contrast is sharply better, glare in bright light is markedly reduced, and reading becomes noticeably easier. The patient did not get their peripheral vision back. They got the clearest possible use of what remained.
That distinction — clearer within the remaining field versus a wider remaining field — is the entire content of honest preoperative counselling for this population. Surgeons who skip it risk a technically excellent surgery a patient still experiences as a disappointment, simply because expectations were never correctly set. Surgeons who get it right give a patient a realistic, achievable win: the cataract's contribution to their vision loss removed, cleanly, with nothing pretended about the part surgery can't reach.
Section 07 — The Agaaz Range
What "no margin
to spare" asks of the tray.
Agaaz does not manufacture anything specific to retinitis pigmentosa — there is no RP-specific IOL or OVD, and none is implied here. What the reasoning above does support is a straightforward point: in a surgical population with unusually little room for error, the quality and design of ordinary cataract-surgery consumables matters more than it does in a standard case, not less.
None of this is a claim that better consumables replace surgical judgment or preoperative counselling — both matter more here than the tray does. It's a narrower, honest claim: given a case with little room for error, using tools built for endothelial protection and PCO prevention is a reasonable, defensible choice, not an upsell. View the complete portfolio →
Section 08 — FAQ
Frequently asked
questions about RP & cataract surgery.
The exact mechanism isn't fully settled, but posterior subcapsular cataract is a well-documented, common finding in RP patients, and it tends to appear at a younger age than in the general population. The degenerating retina and the ongoing inflammatory and metabolic changes inside an RP eye are thought to contribute to earlier lens changes, though a cataract in an RP patient is still a mechanically normal cataract — it forms and is removed the same way a cataract in any other eye does.
Cataract surgery removes the cataract's contribution to vision loss — glare, blur and reduced contrast from a clouded lens — but it cannot reverse the underlying photoreceptor degeneration RP causes. Many patients do gain meaningful, real improvement once the cataract is gone, especially if the retina still has functional area to work with, but the ceiling on that improvement is set by how much retina RP has already taken, not by the surgery. Honest counseling before surgery is essential so the patient understands what is and isn't being fixed.
Multifocal and extended-depth-of-focus IOLs work by splitting incoming light between two or more focal points, which reduces contrast sensitivity and can introduce halos or reduced light throughput compared with a monofocal lens. A retina already compromised by RP has less contrast sensitivity to spare, so most surgeons default to monofocal IOLs in this population — the goal is to give the retina the cleanest, highest-contrast image it can still use, not to add optical complexity on top of an already limited visual budget.
The surgical technique for removing the cataract is largely unchanged, but the margin for error is smaller. An RP eye has less visual reserve to absorb any additional insult, so meticulous endothelial protection during phacoemulsification and gentle capsular handling carry more weight than they would in an eye with an otherwise healthy retina. Pupils in RP eyes can also be smaller and less responsive, which surgeons plan for preoperatively rather than discovering intraoperatively.
Posterior capsule opacification (PCO) is a clouding of the lens capsule that can develop months to years after cataract surgery, caused by residual lens epithelial cells migrating and proliferating across the capsule. It is treatable with a quick outpatient YAG laser procedure, but it still represents a second period of reduced vision. For a patient whose retina is already degenerating and who cannot easily "afford" another visual setback, an IOL with a strong square-edge PCO barrier is a genuinely relevant design consideration, not just a general nice-to-have.
Often yes, even with severely constricted visual fields, because a cataract adds glare, haze and contrast loss on top of whatever field the disease has left — and removing that added blur can still meaningfully improve how a patient uses their remaining central island of vision. The decision is made case by case, weighing how much functional vision remains against surgical risk, which is why preoperative counseling and realistic expectation-setting matter as much as the operation itself in this population.
References & Evidence Base
Peer-reviewed
citations.
Continue Reading
Related guides
from Beyond Vision.
Retinal Disease · Surgeon Series
The retina is
already failing. The lens
doesn't have to.
Retinitis pigmentosa takes vision slowly, from the outside in — night blindness first, then a shrinking field, then, in advanced disease, a narrow island of central sight. Along the way, most patients develop a cataract earlier than their peers. Removing it is routine surgery on a very unforgiving eye: there is little visual reserve left to spend on an avoidable complication, and the lens implant chosen has to respect that.
vs. general population
the typical pattern
in most RP eyes
Section 01 — What Retinitis Pigmentosa Actually Does
Not one disease.
One shared
pattern of loss.
Retinitis pigmentosa (RP) is not a single condition but a group of inherited retinal disorders that share a common mechanism: progressive degeneration of the photoreceptors, the rod and cone cells that convert light into the signal the brain reads as vision. It is the most common inherited retinal degeneration, and it follows a recognisable arc even though the underlying genetics vary widely from patient to patient.
Rods, which are concentrated in the peripheral retina and handle low-light and night vision, are usually lost first. That is why night blindness is typically the earliest symptom, often noticed years or decades before any change in daytime vision. As rod loss spreads, the visual field narrows from the outside in — the classic "tunnel vision" patients describe, though the corridor closes gradually rather than all at once. Cone cells, concentrated in the central macula and responsible for daytime and colour vision, are generally affected later. In advanced disease, a patient can be left with a small island of central vision surrounded by a visual field that has effectively gone dark, even though that central island itself may still register a reasonable letter-chart acuity.
RP is genetic, and the inheritance pattern varies by family and by which of the many genes implicated is involved — autosomal dominant, autosomal recessive and X-linked forms all occur, which is part of why the rate and pattern of progression can differ so much from one patient to the next, and even between the two eyes of the same person. A minority of cases occur as part of a broader syndrome rather than in isolation — Usher syndrome, which combines RP with hearing loss, is the best known example. None of that genetic detail changes how a cataract in an RP eye is surgically managed, but it does explain why two patients with the same "retinitis pigmentosa" label on their chart can present at very different stages and with very different remaining function, which is exactly why a generic surgical plan doesn't serve this population well and an individualised one does.
RP is progressive photoreceptor degeneration, rods before cones, causing night blindness first, then a visual field that constricts from the periphery inward, then — in advanced cases — loss of central vision too. It is genetic, currently has no cure that restores lost photoreceptors, and its rate of progression varies significantly between patients and even between the two eyes of the same patient. What makes RP relevant to cataract surgery specifically is that it also predisposes to an earlier-onset cataract, most often a posterior subcapsular pattern, layering a second, treatable cause of vision loss on top of the one that isn't.
Section 02 — Interactive
Watch the field
close in, stage by stage.
The single hardest thing to communicate about RP to someone who hasn't experienced it is that the visual field narrows gradually, while the remaining central vision can still look sharp on a chart. Select a stage below to see an illustrative approximation of how the usable field changes as RP advances — not a diagnostic tool, and not a specific patient's actual field, but a way to build the right intuition before the surgical discussion that follows.
In early disease, the field is often near-normal by day and the main complaint is night vision — missing a step in dim light, struggling in a poorly lit room, headlights feeling unusually harsh. By moderate disease, patients commonly describe bumping into things at their sides, missing objects that would be in a normal peripheral field, and a growing reliance on turning the head to compensate. In advanced disease, what remains can be a narrow central corridor of vision — still potentially useful for tasks like reading or recognising faces directly in front of them, but offering little to no awareness of anything beside or around that corridor.
Section 03 — The Cataract Connection
Why the lens clouds
earlier when the
retina is already failing.
Cataract is not part of the genetic definition of RP, but it is one of the most consistently reported associated findings, and posterior subcapsular cataract (PSC) in particular shows up disproportionately often in RP patients, frequently at a younger age than typical age-related cataract. The exact mechanism isn't fully settled — proposed contributors include the chronic low-grade inflammatory and oxidative changes associated with ongoing photoreceptor degeneration — but the clinical pattern itself is well documented and familiar to any surgeon who sees a reasonable volume of RP patients.
PSC cataracts have a specific clinical signature relevant here: because the opacity sits at the back of the lens, directly in the visual axis, it tends to cause disproportionate glare and contrast loss relative to its size, especially in bright light or when the pupil constricts. For a patient with a normal retina, that's an inconvenience corrected by routine surgery. For a patient whose retina is already degenerating, that same glare and contrast loss lands on a visual system with far less capacity to compensate — which is a large part of why RP patients often present for cataract surgery with more functional complaint, and often somewhat earlier, than their lens opacity alone might suggest to an examiner comparing it to a standard age-related cataract.
| Factor | Typical age-related cataract | Cataract in RP |
|---|---|---|
| Usual pattern | Nuclear sclerotic or mixed | Posterior subcapsular, disproportionately common |
| Typical age of onset | Later, gradual with age | Often earlier than age-matched peers without RP |
| Retina behind it | Usually healthy | Already degenerating, field already reduced |
| Visual reserve to spare | Typically substantial | Often limited — little margin for additional insult |
| Functional impact of the cataract | Proportional to lens opacity | Can feel disproportionately large given how little field/contrast is left to lose |
None of this changes how the cataract itself is removed — phacoemulsification technique is the same operation regardless of what's happening at the retina. What it changes is how much the surgeon has to get right the first time, because there's less visual budget available to absorb a complication and still leave the patient better off than before.
There's also a practical diagnostic wrinkle worth naming: because RP already causes glare sensitivity and reduced contrast on its own, a mild-to-moderate cataract can sometimes be under-recognised on routine slit-lamp exam in an RP patient, since the examiner may reasonably attribute some of the reported visual complaint to the known retinal disease rather than to a treatable lens change sitting on top of it. A careful, dilated exam that doesn't stop investigating once "the retina explains it" is part of good practice in this population — a genuinely reversible cataract is easy to miss if it's assumed away.
Section 04 — IOL Selection
Why almost every
surgeon reaches for
the same lens type.
Multifocal and extended-depth-of-focus (EDOF) IOLs have become a standard offering in modern cataract surgery for patients who want reduced spectacle dependence, and they work well for many people with a healthy retina. In retinitis pigmentosa, most surgeons make a deliberate, near-universal exception: a monofocal IOL, not a multifocal or EDOF design, is the conventional default.
The reason is optical, not a blanket rule against premium lenses. Multifocal and EDOF optics work by splitting incoming light between two or more focal points simultaneously, which necessarily reduces the light and contrast delivered to any single focal plane compared with a monofocal lens that sends essentially all of it to one point. A retina with normal photoreceptor density and function can usually absorb that trade-off comfortably in exchange for spectacle independence. A retina already losing photoreceptors to RP has less contrast sensitivity to spare, and asking it to also process a split, lower-contrast image is generally considered an unnecessary added burden on a system that's already working with less.
This is a general pattern surgeons apply, not an absolute rule for every case — disease severity, remaining field, patient goals and individual retinal function all factor into a real decision made with a specific patient's retina specialist input where available. But as defaults go, it's about as close to universal as cataract-surgery decision-making gets: give an already-compromised retina the cleanest, highest-contrast image available, and don't add optical complexity it didn't ask for.
Biometry is harder to get right, too
IOL power calculation depends on accurate preoperative measurements — axial length, corneal curvature, anterior chamber depth — and on the patient holding steady fixation while some of those measurements are taken. RP can complicate that step in ways a standard cataract workup doesn't anticipate: nystagmus (involuntary eye movement) is present in some RP patients, especially those with earlier-onset or syndromic forms, and unsteady fixation can reduce the accuracy of keratometry and optical biometry alike. Surgeons managing these cases often take extra measurements, cross-check with more than one biometry method, and build in a wider margin of clinical judgement around the calculated IOL power rather than trusting a single automated readout as they might in a routine case.
Section 05 — What the Reserve Actually Costs
When there's no
margin left, every detail
in the tray matters.
"Limited visual reserve" is a phrase that's easy to say and easy to underweight in practice. It means, concretely, that an intraoperative or postoperative event a healthy-retina patient would barely notice — a few hours of extra corneal edema, a mild inflammatory reaction, a slow-forming PCO two years later — can represent a proportionally much larger hit to an RP patient's already-reduced visual world.
Illustrative representation of how these priorities generally shift for an RP patient relative to a standard-risk cataract case, based on the clinical reasoning described in this article — not a scored index, a validated instrument, or pooled trial data.
retinal degeneration
rods, then cones
cataract surgery alone
None of this is exotic surgery. It's the same phacoemulsification, the same capsulorhexis, the same IOL insertion any cataract surgeon performs routinely. What changes is the tolerance for anything less than the cleanest possible execution — a cohesive-then-dispersive OVD strategy that genuinely protects the corneal endothelium through the phaco step, an IOL with a real square-edge posterior capsule barrier, and gentle, unhurried handling rather than a rushed routine case. In an eye with reserve to spare, small technical shortcuts are usually invisible in the outcome. In an RP eye, they're the difference the patient actually feels.
Section 06 — Setting Honest Expectations
What surgery fixes.
What it can't touch.
The single most important conversation in RP cataract surgery happens before the operating room, not in it. A patient with advanced RP who has heard "cataract surgery" and "vision improvement" in the same sentence needs to leave that conversation understanding precisely what is being offered.
A patient in their fifties with a decades-long RP diagnosis has a visual field reduced to a small central island in each eye, now further clouded by bilateral posterior subcapsular cataracts. Reading has become difficult, faces at a distance are hard to make out, and bright rooms are increasingly uncomfortable. Cataract surgery with a monofocal IOL, careful endothelial protection and a square-edge PCO-barrier lens is performed on the more affected eye first.
The visual field afterward is unchanged — surgery does not touch the RP itself, and nothing about the corridor's width is different. But within that corridor, contrast is sharply better, glare in bright light is markedly reduced, and reading becomes noticeably easier. The patient did not get their peripheral vision back. They got the clearest possible use of what remained.
That distinction — clearer within the remaining field versus a wider remaining field — is the entire content of honest preoperative counselling for this population. Surgeons who skip it risk a technically excellent surgery a patient still experiences as a disappointment, simply because expectations were never correctly set. Surgeons who get it right give a patient a realistic, achievable win: the cataract's contribution to their vision loss removed, cleanly, with nothing pretended about the part surgery can't reach.
Section 07 — The Agaaz Range
What "no margin
to spare" asks of the tray.
Agaaz does not manufacture anything specific to retinitis pigmentosa — there is no RP-specific IOL or OVD, and none is implied here. What the reasoning above does support is a straightforward point: in a surgical population with unusually little room for error, the quality and design of ordinary cataract-surgery consumables matters more than it does in a standard case, not less.
None of this is a claim that better consumables replace surgical judgment or preoperative counselling — both matter more here than the tray does. It's a narrower, honest claim: given a case with little room for error, using tools built for endothelial protection and PCO prevention is a reasonable, defensible choice, not an upsell. View the complete portfolio →
Section 08 — FAQ
Frequently asked
questions about RP & cataract surgery.
The exact mechanism isn't fully settled, but posterior subcapsular cataract is a well-documented, common finding in RP patients, and it tends to appear at a younger age than in the general population. The degenerating retina and the ongoing inflammatory and metabolic changes inside an RP eye are thought to contribute to earlier lens changes, though a cataract in an RP patient is still a mechanically normal cataract — it forms and is removed the same way a cataract in any other eye does.
Cataract surgery removes the cataract's contribution to vision loss — glare, blur and reduced contrast from a clouded lens — but it cannot reverse the underlying photoreceptor degeneration RP causes. Many patients do gain meaningful, real improvement once the cataract is gone, especially if the retina still has functional area to work with, but the ceiling on that improvement is set by how much retina RP has already taken, not by the surgery. Honest counseling before surgery is essential so the patient understands what is and isn't being fixed.
Multifocal and extended-depth-of-focus IOLs work by splitting incoming light between two or more focal points, which reduces contrast sensitivity and can introduce halos or reduced light throughput compared with a monofocal lens. A retina already compromised by RP has less contrast sensitivity to spare, so most surgeons default to monofocal IOLs in this population — the goal is to give the retina the cleanest, highest-contrast image it can still use, not to add optical complexity on top of an already limited visual budget.
The surgical technique for removing the cataract is largely unchanged, but the margin for error is smaller. An RP eye has less visual reserve to absorb any additional insult, so meticulous endothelial protection during phacoemulsification and gentle capsular handling carry more weight than they would in an eye with an otherwise healthy retina. Pupils in RP eyes can also be smaller and less responsive, which surgeons plan for preoperatively rather than discovering intraoperatively.
Posterior capsule opacification (PCO) is a clouding of the lens capsule that can develop months to years after cataract surgery, caused by residual lens epithelial cells migrating and proliferating across the capsule. It is treatable with a quick outpatient YAG laser procedure, but it still represents a second period of reduced vision. For a patient whose retina is already degenerating and who cannot easily "afford" another visual setback, an IOL with a strong square-edge PCO barrier is a genuinely relevant design consideration, not just a general nice-to-have.
Often yes, even with severely constricted visual fields, because a cataract adds glare, haze and contrast loss on top of whatever field the disease has left — and removing that added blur can still meaningfully improve how a patient uses their remaining central island of vision. The decision is made case by case, weighing how much functional vision remains against surgical risk, which is why preoperative counseling and realistic expectation-setting matter as much as the operation itself in this population.
References & Evidence Base
Peer-reviewed
citations.
Continue Reading
Related guides
from Beyond Vision.
Start writing here...
Retinitis Pigmentosa and Cataract Surgery: IOL Selection & Surgical Considerations (2026 Guide)